Established in December 2000, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,700 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Enabling more than 3,700 Innovative Collaborators from more than 30 Countries
Small Molecule Drug R&D and Manufacturing
Cell Therapy
and Gene Therapy
Drug R&D and Medical
Device Testing
Clinical
Services
Small Molecule Drug R&D and Manufacturing
To Become the Most Comprehensive Capability and Technology Platform in the Global Pharmaceutical and Healthcare Industry
WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou
China Electronics Data and WuXi AppTec Form CW Data, a Joint Venture to Offer One-Stop Healthcare Big Data Solutions
WuXi AppTec Provides Easy Access to 80 Billion DNA-Encoded Small Molecules Libraries
